Emerson: Predictive intelligence to reduce operating costs at biopharmaceutical plant

Predictive intelligence software, which

anticipates what needs to be done to maintain optimal operations, will be used

in a new $350 million Lonza biopharmaceutical plant in Singapore, with help from Emerson Process Management.

Predictive intelligence technology , software

that anticipates what needs to be done to maintain optimal operations, will be

used in a new Lonza biopharmaceutical plant in Singapore. Switzerland-based Lonza Group Ltd.

Selected Emerson Process Management to provide engineering and design services

and digital automation architecture and control technologies.

Competitive pressures drive life sciences

companies toward digital automation with predictive intelligence to reduce

overall costs, improve reliability, ensure product quality, meet regulatory

requirements, and optimize operations, says Emerson of its increasing number of

life sciences customers.

Best

practices reduce costs in second Lonza plant

Having installed the automation architecture

in Lonza’s first biopharmaceutical plant in Singapore, Emerson PlantWeb technologies were chosen

for the new plant, expected to be completed in 2010 at a cost of $350 million.

By following the original project models, employing best practices, and

applying the experience gained during design and construction of the original

facility, Emerson is expected to reduce Lonza’s overall costs for the new

plant.

Lonza uses Emerson products and services,

including: PlantWeb digital automation architecture; DeltaV digital automation

system; and intelligent digital devices, including Fisher and Baumann control

valves with Fieldvue digital valve controllers, Rosemount flowmeters and

analyzers, Micro Motion Coriolis flowmeters, and Fisher pressure regulators.

Faster

startups, greater reliability cited

Managing and controlling the highly complex

processes involved in the biopharmaceutical industry is among Emerson

strengths, says Steve Sonnenberg, president, Emerson Process Management. Global

resources of Emerson help meet customers’ objectives for safe, reliable, and

on-time start-up of new manufacturing facilities, he says.

In the Asia-Pacific region, Emerson also has

been awarded automation contracts by Shanghai CP Guojian Pharmaceutical Co.

Ltd. in China; Reliance Life Sciences, DSM

Anti-Infectives India Ltd., and Biocon in India; and the prior Lonza facility in Singapore.

For other recent Emerson news from

MBT, see:

– Cyber

security: Safety instrumented systems, 5 incidents

– Big

buzz: Not all wireless was created equal

– Smart

operations management: Emerson touts new software as MES

replacement

– Edited by Mark T. Hoske, electronic products editor, MBT, www.mbtmag.com

Do you have experience and expertise with the topics mentioned in this content? You should consider contributing to our WTWH Media editorial team and getting the recognition you and your company deserve. Click here to start this process.